Moreover, the possible increase in this incidence following irradiation is relatively low, so the studies must have sufficient statistical power, which requires large cohorts. Moreover, in large populations confounding factors are present and they must be taken into account by appropriate statistical methods because their specific effect can be much greater than the effect of radiation. Thus the effect of low doses remains doubtful. For example, in a study investigating the risk of lung cancer due to radon in homes, not taking smoking into account would make the results impossible to interpret. However, it is highly unlikely that putative carcinogenic risks could be estimated or even established for low doses through case-control studies or the follow-up of cohorts. Even for several hundred thousands of subjects, the power of such epidemiological studies would not be sufficient to demonstrate the existence of a very small excess in cancer incidence or mortality adding to the natural cancer incidence. Because of these epidemiological limitations, the only method for estimating the possible risks of low doses (< 100 mSv) is extrapolation from carcinogenic effects observed between 0.2 and 3 Sv.
A linear no-threshold relationship (LNT) is often used for that purpose. The LNT model, used in 1956 by Russell to evaluate the radio-induced mutations in the germ cell line in the mouse, was introduced between 1960 and 1980 for the purposes of regulation in radioprotection with regard to all mutagenic and carcinogenic effects in humans. At that time, LNT was considered a convenient pragmatic relationship but not a model based on scientific data. In the 1960s, the International Commission of Radioprotection (ICRP) introduced it because it allows the addition of sequential irradiation delivering low or high doses of radiation received by an individual whatever the dose rate and the fractionation. Thus it greatly simplifies accounting in radioprotection. However, gradually LNT was interpreted as meaning that the carcinogenic risk is proportional to the dose and that even the smallest dose induces a cancer risk. Thus the LNT has been used for assessing the effect of low and very low doses. This procedure has become a dogma in many radioprotection circles, but the validity of the LNT has been challenged over the past decade for two main reasons: a) the meta-analyses of the animal data have shown the absence of any carcinogenic effect of doses below 100 mSv, b) scientific progress has revealed the complexity of carcinogenesis, and the diversity and effectiveness of the responses of a cell to irradiation. Indeed, a cell is not passively affected by the accumulation of lesions induced by ionizing radiation. It reacts through several mechanisms.
2 -The rapidly growing knowledge in molecular biology and radiobiology during the last decade should lead us to examine the validity of the implicit assumptions on which the use of LNT has been based for assessing the carcinogenic effect of low doses (< 100 mSv) and a fortiori of very low doses (< 10 mSv) on the basis of that observed in the range of doses of 0.2 to 3 Sv. The LNT model postulates that the cell reacts in the same way regardless of dose rate and dose, which implies that the probabilities of death and mutation (per unit dose) and the contribution to carcinogenesis of each physical event remains constant irrespective of the number of lesions in the cell and in the neighboring cells. This constancy implicitly admits several hypotheses: a) In the range of the doses and dose rates under consideration, there is no physical, chemical or biological interaction between the effects caused by the various tracks of ionizing particles in a cell. b) Any absorbed dose of energy in a cell nucleus leads to a proportional probability of mutation. The probabilities of successful repair or misrepair (per dose unit) are always the same, whatever the number of lesions in the same cell. There should be no impact of dose or dose rate. Similarly, the probability of apoptosis does not vary with dose. c) Any DNA lesion has the same probability of giving rise to a cancer, irrespective of the number of other lesions in the same cell and the neighboring cells.
These hypotheses are not consistent with current radiobiological knowledge which shows that cells do not remain passive when they are irradiated either by solar UV or by ionizing radiation. Moreover intercellular communication systems inform a cell about the presence of an insult in neighboring cells.
2.1
The oxidative stress induced by the irradiation induces several defense mechanisms against the reactive oxygen species. The reactive oxygen species, formed by water radiolysis induced by irradiation, damage some cell constituents and produce oxidative stress. This oxidative stress stimulates enzyme systems that detoxify active species of oxygen formed and induces the synthesis of enzymes that destroy them. In parallel, oxidative stress also activates numerous signaling pathways. DNA damage or modifications of the chromatin are detected by signaling proteins. The activity of these proteins is modulated by the number of lesions (and therefore by the dose, the dose rate and LET) and by messages from neighboring cells. These proteins activate phosphokinase transmitters, in particular the protein encoded by the ATM gene (which is mutated in ataxia-telangiectasia) and the ATR gene. In turn, these transmitters modulate the action of proteins involved either in cell cycle control (the interruption of which promotes repair) and DNA repair, or in triggering apoptosis.
Studies carried out with the DNA micro-array technique in yeast show that continuous irradiation, at a dose rate of 20 mGy/h, i.e. lower than the level of irradiation that causes a detectable biological effect (lethal, mutational), is enough to change intracellular signaling without modifying the genome and to activate or inhibit numerous genes involved in the general metabolism and in defenses against ionizing radiation. Such mechanisms bring into play defenses at doses of the same order as those due to natural irradiation, which makes it possible to reduce or prevent its potentially harmful effects. The dose rate determines the average time interval between physical hits; it has a major effect on the cellular response. In general, the biological effects of irradiation (lethality, mutagenesis, chromosomal aberration, etc.) decrease as the dose rate decreases. This may be due to the fact that when the dose rate is low, the number of DNA damages simultaneously present in the cell is limited. Conversely, a high dose rate leads to the simultaneous presence of a large number of damages. This high local density of damages interferes with the coordinated action of repair systems, and also increases the probability of error prone endjoining due to the presence of several double strand breaks (DSBs) in a restricted volume.
2.3 These conclusions regarding differences in the efficacy of the protection system are supported by various experimental or clinical data, which highlight the impact of repair on the biological consequences of irradiation:
2.3.1 The effectiveness of DNA repair systems is evidenced by the lack of any reduction in the mutagenic and lethal effect as the dose rate decreases in the cell lines in which the signaling or the DNA repair systems are impaired or blocked, for example, in hereditary diseases with defects in repair systems (reparatoses). This lack of repair is also observed when yeasts or mammalian cells are exposed to gamma rays at 0°C (a temperature that inhibits the repair enzymes), at that temperature the number of DNA double strand breaks is then identical at high and low dose rates, whereas at room temperature, it is much smaller at lower dose rates.
2.3.2 At equal doses, the mutagenic effect varies markedly with the dose rate. When the dose rate increases, the mutation frequency after having passed through a minimum The lower lethality following fractionated irradiation cannot only be explained by the repair of DNA lesions between sessions. Recent data also show that the effectiveness and rapidity of repair depend on the time, the type of tissue and its proliferative status.
Low dose hyper-radiosensitivity
For some cell types, mortality is very high (per dose unit) at the onset of irradiation (during the first two hundred mGy), then falls to a very low level before subsequently increasing again. This low dose hypersensitivity is observed in many cell types leading to a high mortality rate, per dose unit, for doses of less than a few hundred mGy of low LET irradiation. An induced radioresistance is observed at doses of over 0.5 Gy; and the mortality rate per dose unit then becomes very low before increasing again. These variations in the mortality rate (per dose unit) indicate that the cellular defense mechanisms against lethality, which initially show little efficacy, become more effective during irradiation (Chalmers et Rothkamm et al (2003) have shown that there is a linear relationship between DSB number and dose between 1.2 mGy and 2 Gy. But after a low dose (1.2 mSv) there is no evidence of DNA repair, furthermore when cells are cultivated, 24 hours later, after a low dose, no excess in the number of cells with a DSB can be detected; this disappearance can be due either to cell death caused by the absence of repair, or to a combination of error-free repair and apoptosis. When only a few cells are damaged, this elimination strategy seems to be optimal, because repair systems may be error prone and can potentially lead to the emergence of pre-cancerous and subsequently cancerous cells. Schematically, one can distinguish between four dose ranges.
The experiments of
-At doses below a few mGy or low dose rates, no damage can be detected because the damaged cells die. At these doses, the signaling systems are not triggered. Only constitutive repair systems, which are constantly active, operate (such as BER). The doses or dose rates above which apoptosis is stimulated seem to be lower than those that activate the repair systems.
-For doses between about 10 and 100 mGy or those delivered at low dose rates, damaged cells are eliminated or whenever possible, repaired by high fidelity mechanisms. When this elimination/repair mechanism has been induced by irradiation, it also acts upon the cells damaged by oxidative metabolism. In combination with the detoxification mechanisms induced by oxidative stress, these defenses can also explain the hormesis effect which is frequently observed in experimental animals. However, the possibility of a misrepair cannot be excluded; infallibility does not exist but errors can be very rare.
-At higher doses, over approx. 200 mGy, the concentration of damaged cells increases and the DNA repair systems aimed at avoiding cell death and tissue injuries are associated with a risk of misrepair, which is greater when the number of lesions inside the cells is high. In the absence of apoptosis, which is less effective at high doses, these errors lead to mutations. When apoptosis or senescence predominates, the risk of cancer is very low, but the tissue loses cells. When repair predominates, the risk of cancer increases. This phenomenon is also observed during ultraviolet irradiation of the skin. Because of these variations in effectiveness of DNA repair and in the probability of apoptosis (in relation to dose or dose rate), the carcinogenicity of irradiation increases more rapidly than the dose, leading to a curvilinear relationship.
-Above 500 mGy, a stimulated proliferation, in order to compensate for cell deaths, is observed. Cell divisions interfere with repair and increase the likelihood of errors.
4.4 The cell response therefore seems to depend on the dose, the dose rate and the cell type, and on the concentration of damaged cells. It varies over time. This strategy of defense that the organism raises against cellular lesions induced by ionizing radiation is distinct from, but somewhat similar to the strategy observed after ultraviolet irradiation. Once again, the accumulation of lesions hinders and delays repair, and therefore increases harmful effects per dose unit of exposure.
One can also draw a parallel between dose effect relationships for ionizing radiation and the numerous experimental data that reveal major differences between the toxicities of chemicals depending on dose, and that have shown very small (if any) carcinogenic effects of low concentrations. However, these variations are also partly linked to changes in metabolism, which may contribute to non-linearity.
4.5 The lack of validity of the LNT relationship for chromosome aberrations at low doses with low LET radiation is not surprising. The occurrence of a chromosome aberration is much increased when there are two or more DNA double-strand breaks in the same chromosome or neighboring chromosomes, making it possible that the rejoining of the fragments either does not restore the molecule to its initial condition (inversion or translocation within the same chromosome), or even rejoins fragments that do not belong to the same chromosome. The probability of such error-prone endjoining therefore depends on the number of breaks simultaneously present in a limited volume, and therefore decreases markedly with dose rate and is not proportional to dose but to the square of the dose. LNT cannot be used to predict chromosome aberrations for very low doses. A threshold is conceivable.
The dose-effect relationship for cell lethality is not linear but linear-quadratic. The phenomenon of initial hyperadiosensitivity (Joiner) shows that it is necessary to introduce a correction into the linear-quadratic relationship for doses of less than 200 mGy.
4. 6 All data clearly show that the efficacy of defense mechanisms against the lethal effect and the mutagenic effect of ionizing radiations, varies with the cell line. This efficacy appears to be in all cell lines very high at low doses and dose rates such as those delivered by the natural irradiation but it declines at higher doses. These variations in the efficacy with dose is not surprising since many mechanisms have emerged during evolution to protect procaryote cells against the lethal effect of the natural ionizing (or U.V) radiation. After the appearance 600 million years ago of multicellular organisms the aim of defense mechanisms had also the purpose of protecting multicellular organisms against the appearance of mutant cells. This research area is developing rapidly. Its aim is to find out whether the by-stander effect and genetic instability could play a part in the onset of radio-induced cancers. Overall, at the experimental level, the existence of direct link between carcinogenic effects and genetic instability remains hypothetical, in particular after low doses of low LET radiation. Genetic instability could be an indicator, cause, or consequence of cellular defects, such as impaired DNA repair. The most convincing evidence against the bystander effect and genetic instability playing a role in inducing human cancers is provided by studies on subjects contaminated by radium or thorium and followed-up until their death over more than fifty years after contamination, and in whom no cancer was detected when the dose was below a few Gy, whereas there were many cancers at higher doses. If present in these individuals, the bystander effects or genetic instability would have shown up as a long term effect in the form of an increased cancer incidence.
-Radiocarcinogenesis

5.1
The conventional model acknowledged that, by a series of stages, stochastic alterations of the genome confer a selective advantage to a initiated cell, during carcinogenesis. We now know that these phenomena cannot be described by a linear process, during which successive genome damage of one cell accumulates at random. Carcinogenesis cannot be reduced to a series of mutations occurring in the same cell (Brash) . Indeed it affects all aspects of genome function.
The association of genetic and epigenetic mechanisms is now well-established.
The cell, the tissue and the body all have defenses against carcinogenic processes, and these must be successively overcome for carcinogenesis to occur. There are intracellular systems of proliferation control (suppressor genes), and mechanisms involving the death of initiated cells that tend to eliminate or prevent the proliferation of cells in which a protooncogene has mutated into an oncogene or with damaged DNA, or which do not obey systems regulating proliferation, or which are no longer receiving the growth factors required for their growth.
Cell death appears to be a main safeguard mechanism, in particular programmed death or apoptosis. The loss of a cell's ability to kill itself may result from changes in the genes involved in this process. Ionizing radiations are likely to induce, at different levels depending on the tissues, apoptotic responses, which are the consequence of intra-and intercellular signaling. However, they can also induce mutations, which interfere with apoptosis and therefore permit the survival of damaged cells, which in turn constitutes one of the steps in carcinogenesis (Brash). In animals that have received chemical carcinogens, irradiation has little influence on the emergence of cancer, whereas, following X-ray irradiation, UV irradiation promotes the appearance of cancers.
At the whole body level, escape from the immune surveillance responsible for eliminating tumor cells is based on selection of cells that are capable of escaping from it, for instance by the loss of expression of the components of the major histocompatibility complex.
Carcinogenesis may be facilitated by a reduction in immune defenses (Tanooka, Euvrard) especially when a large segment of the body has been irradiated.
-Animal Experimentation
Animal experimentation has made a major contribution to our understanding of the carcinogenic effects of ionizing radiation. The proportions of radiocancers vary, depending on the species, age, sex and tissues concerned and the dose-effect relationships are very variable.
Despite the favorable conditions of animal experimentation, it has neither been possible to establish a statistically significant carcinogenic risk for doses less than 100 mSv, nor to exclude its existence, which is obviously much more difficult. With only a few exceptions, no excess tumors are observed below 500 mGy for low LET radiations.
Animal experiments, notably in the mouse, allow the study of dose-effect relationships for cancer induction over a large range of external exposure levels. A large number of data is compatible with a linear-quadratic model. However, some data are not satisfactorily fitted with this model. In properly conducted studies in the mouse, some data are better fitted by a quadratic relationship without a linear component or by relationships with a threshold than by a model with a linear, no-threshold component. A considerable reduction in the carcinogenic effects has been observed with low LET, low dose and low dose rate radiation. This attenuation is particularly obvious after contamination of the lungs by beta and gamma emitters and even after exposure to radon. It is observed for all the tumors induced by external low LET irradiation. This observation explains why the RBE (Relative Biological Effectiveness) of neutrons increases constantly as an inverse function of the square root of the neutron dose without ever levelling off. This suggests that photons exhibit dose-effect relationships that either have a threshold, or are purely quadratic. Threshold relationships have also been established for pulmonary tumors induced by alpha radiation in rats, and for bone tumors in dogs.
Heterogeneous irradiation, in particular following internal contamination by radionuclides, shows major reduction of the low dose rate effects, with a quasi-threshold, in most cases. This lower efficacy compared to the same dose of uniform irradiation is also observed following irradiation through a grid; it seems to be associated with the control exerted by neighboring cells. A meta-analysis (Tanooka 2001 ) has shown that the carcinogenic effect of a localized irradiation is much smaller than that of a total body irradiation or when a large segment of the body is irradiated, which suggests the impact of immunosurveillance. These two sets of data show that radiocarcinogenesis cannot be interpreted only by the damage caused to the genome of a cell.
Another meta-analysis (Duport 2003) has shown that among the experimental studies in which the incidence of cancer was sufficiently high in control animals, a reduction of this incidence was observed following low dose irradiation in 40% of them. This observation is consistent with the concept of hormesis. This finding does not justify generalization of this concept; however, it does confirm its existence.
In summary, animal experiments show the existence of a dose below which no excess in tumor incidence is detectable, which suggests the existence of a practical threshold.
Furthermore, most of the dose-effect relationships are not linear but rather linear-quadratic or quadratic and a hormesis is observed in about 40% of the experiments. The existence of a threshold is particularly obvious following contamination by α-emitter radionuclides. It is of interest that the same observation is made in humans because it shows that animal data can provide useful information for humans.
-Epidemiology
Carcinogenesis by long half-life α-emitting radionuclides
When an α-particle crosses a nucleus, the dose received by the cell is approx. 4. Cells that cause cancers may not be induced directly but by a bystander effect. This mechanism is effective only at high doses.
On the basis of present knowledge, it is difficult to choose between these hypotheses but these data show that, with this type of irradiation, the bystander effect and radiation-induced genomic instability do not cause cancer when the number of damaged cells is small.
Moreover, none of these hypotheses is compatible with the postulates on which the LNT relationship is based. In fact it appears that the data on the carcinogenic effect of in utero irradiation has not sufficient robustness to be the basis for evaluating the risk of low doses. Whatever the value of the Oxford study, some inconsistencies in the available data sets call for great caution before concluding the existence of a causal relationship from data showing simply an association. Furthermore, it is highly questionable to extrapolate from the fetus to the child and adult. c) In the annex 4 (epidemiology), an analysis is carried out on 20 different surveys comprising a total of 415,000 individuals having received doses from 10 to 100 mSv above the usual dose of natural irradiation. The incidence of solid tumors was slightly decreased and that of leukemia was slightly increased. Neither of these two differences was statistically significant. This preliminary study shows the feasibility of a meta-analysis of human data.
Currently we cannot conclude from a survey showing a small and non-statistically significant difference in cancer incidence that doses below 100 mSv either increase or decrease cancer incidence.
d) The current uncertainties regarding the carcinogenic effect of low dose irradiation underlines the interest of comparing the incidence of cancer and congenital malformations in geographic regions with high or low dose natural irradiation background and similar lifestyle.
Currently the data of studies carried out in India and China have not detected any differences, although chromosomal aberrations in the circulating lymphocytes confirm the high level of irradiation. These data are consistent with the hypothesis of a threshold but the data are not yet conclusive and the studies must continue.
Current radiobiological data are not consistent with the implicit assumptions on which the LNT is based. All the data show the lower effectiveness of low doses and dose rates.
Morevover, the quantitative discrepancy between the results of the various epidemiological and animal experimental studies supports the view that there are several dose-effect relationships rather than only one, and that their parameters depend upon the type of cancer, the type of ionizing particles, radiation dose, dose rate, fractionation of irradiation, species, 
-Comparison between the Joint Report and the BEIR 7 Report
The joint report was released in March 2005. Four months later, in July 2005, the BEIR 7 report was published. Contrarily to the French Academies report, it concludes that the linear no-threshold relationship (LNT) should be used for assessing the carcinogenic risks of low or very low doses. Since both reports rely to a large extent on the same data, the causes of this disagreement needs to be investigated. We shall consider below the various sources of this controversy.
Epidemiology
Both reports reach the same conclusion: There are no convincing data demonstrating a carcinogenic effect of doses below 100 mSv delivered to infants, children or adults. This is an important conclusion. Not long ago some proponents of the LNT claimed that the analysis of the data of A-bomb survivors (Brenner et al 2003) showed an excess of solid tumors after low doses. However, this conclusion was open to question because the statistical methodology used in these papers mixed individuals who had received up to 125 mSv. It was therefore felt their conclusions for doses below 100 mSv were not convincing. The same remarks can be made regarding the data on radiation workers (Cardis 2005 ).
However, there are two major differences between the Joint Report and the BEIR report.
The first concerns in utero irradiation. BEIR 7 acknowledges the existence of a controversy regarding these data but concludes that doses of 10-20 mSv delivered to the fetus were responsible for an excess in the incidence of leukemia and solid tumor. As discussed above, the conclusions of the Joint Report are different. The association may have been linked with various biases, such as an underlying maternal disease leading to both the X-ray examination and the excess of cancer incidence. Furthermore, the doses delivered at that time to fetuses may have been, in some cases, much larger than those calculated. Risks of leukemia were not increased among the offspring of Japanese atomic bomb survivors who were pregnant at the time of the bombing; and no increase was observed in twin studies and in several cohort studies or recent surveys (Naumburg, Shu).
The second difference regards workers contaminated with radium and patients contaminated with thorium. In both series the follow-up is longer than for the A-bomb survivors, the number of individuals contaminated is large, cancers (osteosarcoma or liver cancers) are observed following high doses but not following low doses and the existence of a threshold is obvious and not disputed (at about 10 Gy for radium [Carnes] and 2 Gy for hepatomas). As discussed above, several hypotheses, which are not mutually exclusive, can be made to explain the absence of cancer (Tubiana 2003) . Whatever the mechanism involved, these data are not consistent with a linear relationship. These data are of great importance because, at equal doses, the α-particles are at least as carcinogenic as electrons. The omission of these data in the BEIR 7 report is surprising. Is it because these data correspond to heavy particles? The BEIR 7 report is devoted to low doses (below 100 mSv) and yet over ninety percent of the report discusses effects resulting from much higher doses, which is understandable because data should be put in perspective. Therefore data concerning α-particles should not be omitted. Unfortunately, the carcinogenic effect of low doses of radon is difficult to appreciate in humans because of the possible bias associated with tobacco; nevertheless the existence of a dose rate effect with radon suggests a non-linearity (Monchaux).
Animal Data
The BEIR 7 acknowledges, as does the Joint Report, that most animal dose-effect relationships are not linear but are either linear-quadratic, quadratic or with a practical threshold or even an hormetic effect. However, the BEIR 7 report does not discuss two important review papers, those of Tanooka (2001) and Duport (2003) which showed the high proportion of animal data with practical threshold or an hormetic effect. These two papers are not quoted in the BEIR report. If this is because the writers of the report disagree with their conclusions, it is regrettable that they do not explain why.
The BEIR report is entirely based on a technical NRPB memorandum by A.A. Edwards (1992), which unfortunately is not available in the libraries that we consulted. Therefore we were unable to check whether it is consistent with the more recent data. At any rate, there is a clear disagreement between the interpretation of the animal data in the BEIR 7 and the Joint Report. Report argues that in these conditions the incidence of mutations should not increase linearly with doses since the mutagenic effect should be greater at high doses or high dose rate.
However, surprisingly, the BEIR report does not discuss this point. However, the lack of DNA repair was reported after a much lower dose (1.2 mGy). Hence there is no contradiction between the two sets of data, but the threshold above which the cells do not disappear and repair is triggered is unknown (between 5 and 15 mGy). (Brash) . Moreover, a large number of recent data have shown the role in carcinogenesis of interaction between the initiated cell, the surrounding normal cells, the stoma, and the immunocompetent cells which infiltrate tissues and tumors. The experimental data concerning contamination by radionuclides (β or α emitters) suggest that a single isolated mutated cell has a very low probability of originating a detectable tumor. This conclusion is consistent with the epidemiological data, discussed above, made on individuals contaminated with α-emitters such as radium or thorium. The BEIR report and the tentative ICRP report do not discuss these data.
8.5 Although the BEIR 7 report advocates the use of LNT, it gives a great importance to the DDREF and advises a dose-effect relationship which embodies a DDREF factor and which is therefore not linear but curvilinear. However, surprisingly, the BEIR report does not discuss the mechanisms which are involved in the DDREF. It is likely that the lower mutagenic effect of a low dose rate is related to a better DNA repair and is not observed in cells with an impaired DNA repair.
8.6 In summary, the divergences between the Joint Report and the BEIR are not as great as they may appear. The BEIR 7 report conclusion (p. 443) is: "The committee judges that the balance of evidence from epidemiologic, animal and mechanistic studies tends to favor a simple proportionate relationship at low doses between radiation dose and cancer risk." But, this sentence is followed by a word of caution: "Uncertainties on this judgment are recognized and noted." Nevertheless, the report recommends the use of the linear no threshold relationship (LNT) for assessing the risks of small or very small doses. Conversely, the Joint Report states that the use of LNT for assessing the risks of doses below 20 mSv is unjustified and should be discouraged. The Joint Report feels that the most recent data clearly show the efficacy of the two guardians of the genome, DNA repair and programmed cell death, varies with doses and dose rates, whereas the BEIR 7 report is skeptical and does not take these data into account. With regard to carcinogenesis, the BEIR 7 report assumes that lesions accumulated in a single cell suffice to initiate a carcinogenic process. However, the Joint Report points out that the analysis of animal data and the lack of a carcinogenic effect in subjects contaminated with α-emitter nuclides is not consistent with this assumption.
Moreover, several recent data show that cancer is not simply a cellular disease but also involves dysfunction of the tissue control and immunosurveillance, such as those which are observed after the death of a large proportion of cells. Therefore the basic radiobiological assumptions of the LNT are not in accordance with recent data.
